-
Kindred Bio (KIN) Prices 3M Offering at $18/Share
-
BMO Capital Upgrades Kindred Biosciences (KIN) to Speculative Outperform
-
BMO Capital Downgrades Kindred Biosciences (KIN) to Market Perform
-
BMO Capital Starts Kindred Biosciences (KIN) at Outperform
-
Kindred Biosciences (KIN) IPO Opens Sharply Higher
-
Kindred Biosciences (KIN) IPO Prices at $7, Middle of Range